+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Drug Approval"

Pharmacovigilance Market Report 2025 - Product Thumbnail Image

Pharmacovigilance Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
ADME Toxicology Testing Market Report 2025 - Product Thumbnail Image

ADME Toxicology Testing Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Aptamers Market Report 2025 - Product Thumbnail Image

Aptamers Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
From
From
From
From
From
Biosimulation Market Report and Forecast 2024-2032 - Product Thumbnail Image

Biosimulation Market Report and Forecast 2024-2032

  • Report
  • April 2024
  • 140 Pages
  • Global
From
Orphan Drugs Market 2024-2028 - Product Thumbnail Image

Orphan Drugs Market 2024-2028

  • Report
  • August 2024
  • 180 Pages
  • Global
From
From
From
From
From
From
From
Loading Indicator

The Drug Approval market is a key component of the Drug Discovery process. It involves the evaluation of a drug's safety and efficacy by regulatory authorities, such as the US Food and Drug Administration (FDA). This process is essential for the approval of a drug for commercial use. It involves the submission of a New Drug Application (NDA) to the FDA, which includes data from pre-clinical and clinical trials. The FDA then reviews the data and makes a decision on whether to approve the drug. The Drug Approval market is highly competitive, with many companies vying for approval of their drugs. Companies in the Drug Approval market include pharmaceutical companies such as Pfizer, Merck, and GlaxoSmithKline, as well as biotechnology companies such as Amgen and Genentech. Other companies involved in the market include contract research organizations (CROs) and clinical research organizations (CROs). Show Less Read more